These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 19816987)

  • 21. Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
    Hallstrom AP; Wyse DG; McAnulty J; ;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):159-66. PubMed ID: 18810620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R
    Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias.
    Zivin A; Bardy GH
    Am J Cardiol; 1999 Nov; 84(9A):63R-68R. PubMed ID: 10568662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.
    Ezekowitz JA; Armstrong PW; McAlister FA
    Ann Intern Med; 2003 Mar; 138(6):445-52. PubMed ID: 12639076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH).
    Oseroff O; Retyk E; Bochoeyer A
    Curr Opin Cardiol; 2004 Jan; 19(1):26-30. PubMed ID: 14688631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-arrhythmic drugs interaction and defibrillation threshold in patients with implantable cardioverter defibrillator].
    de Vasconcelos JT; Galvão Filho Sdos S; Barcellos CM
    Arq Bras Cardiol; 2003 Mar; 80(3):336-9. PubMed ID: 12856278
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current challenges in sudden cardiac death prevention.
    Corrado D; Zorzi A; Vanoli E; Gronda E
    Heart Fail Rev; 2020 Jan; 25(1):99-106. PubMed ID: 31346843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arterial hypertension and cardiac arrhythmias].
    Vester EG
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S261-5. PubMed ID: 19085803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular arrhythmias in heart failure.
    Batsford WP; Mickleborough LL; Elefteriades JA
    Cardiol Clin; 1995 Feb; 13(1):87-91. PubMed ID: 7796435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of sudden cardiac death.
    Moss AJ
    Hosp Pract (Off Ed); 1992 Nov; 27(11):165-8, 173-6. PubMed ID: 1429940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should an implanted defibrillator be considered in patients with vasospastic angina?
    Eschalier R; Souteyrand G; Jean F; Roux A; Combaret N; Saludas Y; Clerfond G; Barber-Chamoux N; Citron B; Lusson JR; Brugada P; Motreff P
    Arch Cardiovasc Dis; 2014 Jan; 107(1):42-7. PubMed ID: 24373622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis.
    Bernardo P; Conforti ML; Bellando-Randone S; Pieragnoli P; Blagojevic J; Kaloudi O; Guiducci S; Porta F; Padeletti L; Gensini GF; Matucci-Cerinic M
    J Rheumatol; 2011 Aug; 38(8):1617-21. PubMed ID: 21632680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lipid-altering therapies on ventricular arrhythmias and sudden cardiac death.
    Majmudar MD; Tompkins C; Bachmann JM; Blumenthal RS; Marine JE
    Cardiol Rev; 2009; 17(2):60-9. PubMed ID: 19367147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of sudden cardiac death.
    Prystowsky EN
    Clin Cardiol; 2005 Nov; 28(11 Suppl 1):I12-8. PubMed ID: 16450808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.